ONI manufactures the Nanoimager, a compact super-resolution microscope designed to make molecular imaging accessible to research labs without specialist expertise or industrial-scale budgets. The tech stack is frontend-heavy (React, TypeScript, Next.js, Tailwind) paired with standard analytics (Tableau, Looker) and CRM (HubSpot, Salesforce), suggesting a product-driven sales model. Active hiring skews toward director-level roles across engineering and sales, with acute focus on manufacturing readiness, quality systems, and regulatory compliance—typical of a hardware company scaling from prototype to production.
ONI is a UK-based biotech hardware company founded in 2016, headquartered in Oxford. The Nanoimager is a fluorescence microscope capable of super-resolution imaging (dSTORM, PALM, single-molecule tracking) in a form factor small enough for lab benchtops. The product targets researchers studying protein, DNA, and RNA in cells, tissues, viruses, and nanoparticles. The company operates across 51–200 employees with active product development, manufacturing transfer, and regulatory pathways. Current priorities include scaling quality management systems for early-stage manufacturing, managing product safety risks, ensuring UKCA/CE compliance, and expanding pharma customer reach.
ONI's flagship product is a compact desktop super-resolution microscope designed for non-expert scientists to image molecules at high resolution. It supports techniques including dSTORM, PALM, single-molecule FRET, and single-particle tracking.
Frontend: React, TypeScript, Next.js, Tailwind CSS, Material-UI. Data/analytics: Tableau, Looker, SQL. CRM: HubSpot, Salesforce. QA: Jest, React Testing Library, Cypress. No major tech adoptions or replacements currently reported.
Other companies in the same industry, closest in size